Latest News
Lantheus Holdings (LNTH) appears undervalued with strong fundamentals. Its low P/E ratio, robust profitability, and healthy balance sheet make it a compelling value investing candidate.
Via Chartmill · November 4, 2025
Via Benzinga · November 4, 2025
Marzetti Company (MZTI) reported record Q1 earnings and revenue, beating analyst estimates with strong performance in both Retail and Foodservice segments.
Via Chartmill · November 4, 2025
Kymera Therapeutics stock rises on positive clinical updates for its atopic dermatitis drug, KT-621, despite missing Q3 2025 revenue and EPS estimates.
Via Chartmill · November 4, 2025
The iPhone maker is expecting robust sales in its upcoming quarter.
Via The Motley Fool · November 4, 2025
The Euro reverses previous gains before diving below 1.1500 against the US Dollar.
Via Talk Markets · November 4, 2025
You've probably heard that postponing Social Security until age 70 is the "smart" move. Here's why so few people plan to follow the advice.
Via The Motley Fool · November 4, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · November 4, 2025
Spotify is orchestrating an impressive financial turnaround, blending strategic price increases with its rapidly expanding audiobook library to drive fourth-quarter profitability far beyond Wall Street expectations.
Via Talk Markets · November 4, 2025
Neuronetics (STIM) Q3 2025 results: revenue miss sparks a 22% stock drop despite a narrower-than-expected EPS loss.
Via Chartmill · November 4, 2025
ADT Q3 2025 earnings: Revenue slightly missed estimates, but profit beat forecasts. The company also narrowed its full-year guidance and highlighted strong cash flow.
Via Chartmill · November 4, 2025
Anywhere Real Estate (HOUS) missed Q3 2025 revenue and EPS estimates, reporting $0.00 EPS versus a $0.23 forecast, signaling profitability challenges.
Via Chartmill · November 4, 2025
Mosaic has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Via Barchart.com · November 4, 2025
Dredging and coastal protection company Great Lakes Dredge & Dock (NASDAQ:GLDD) missed Wall Street’s revenue expectations in Q3 CY2025 as sales rose 2.1% year on year to $195.2 million. Its GAAP profit of $0.26 per share was 50.7% above analysts’ consensus estimates. 
Via StockStory · November 4, 2025
Vital Farms (VITL) Q3 2025 earnings beat estimates with revenue of $198.9M and EPS of $0.36. The stock surged over 8% as the company raised its full-year outlook.
Via Chartmill · November 4, 2025
Uber's Q3 2025 earnings beat on profit but weak Q4 guidance caused a stock dip, highlighting strong operational growth overshadowed by future concerns.
Via Chartmill · November 4, 2025
Global hospitality company Marriott (NASDAQ:MAR) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 3.7% year on year to $6.49 billion. Its non-GAAP profit of $2.47 per share was 3.5% above analysts’ consensus estimates. 
Via StockStory · November 4, 2025
Bowhead Specialty Holdings (BOW) beat Q3 earnings estimates with strong premium growth and a 30.9% jump in investment income, despite a slight stock dip.
Via Chartmill · November 4, 2025
UL Solutions beats Q3 2025 earnings and revenue estimates, posting strong profit growth and raising its full-year outlook.
Via Chartmill · November 4, 2025
Wingstop's Q3 2025 earnings beat EPS estimates but missed revenue targets, causing a stock dip despite record unit growth and profitability.
Via Chartmill · November 4, 2025
InspireMD (NSPR) Q3 2025 results beat revenue estimates by 40%, driven by the successful U.S. launch of its CGuard Prime carotid stent system.
Via Chartmill · November 4, 2025
Super Micro Computer has significantly outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.
Via Barchart.com · November 4, 2025
Rhythm Pharmaceuticals posts mixed Q3 2025 results, missing revenue estimates. Despite the loss, the company highlights strong drug growth and key regulatory milestones for its obesity treatments.
Via Chartmill · November 4, 2025
The animal health company now expects $9.4 billion-$9.475 billion in sales for the year.
Via Investor's Business Daily · November 4, 2025
Taysha Gene Therapies stock fell after Q3 results, with a revenue miss overshadowing positive FDA Breakthrough Therapy designation for its Rett syndrome drug.
Via Chartmill · November 4, 2025
First Watch's Q3 2025 earnings show a revenue beat but an EPS miss. The stock faced pressure despite strong same-store sales growth of 7.1% and aggressive restaurant expansion.
Via Chartmill · November 4, 2025
Global alternative asset manager TPG (NASDAQ:TPG) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 168% year on year to $1.22 billion. Its GAAP profit of $0.20 per share increased from $0.04 in the same quarter last year. 
Via StockStory · November 4, 2025
Ball Corp. (BALL) reports Q3 results exceeding expectations in revenue and in line with earnings estimates.
Via Benzinga · November 4, 2025
Nuveen Churchill Direct Lending (NCDL) reported mixed Q3 2025 results, beating EPS estimates but missing on revenue. NAV dipped slightly amid market shifts.
Via Chartmill · November 4, 2025
Learn how a proven growth investing strategy identified Palantir (PLTR) as a top stock, highlighting its explosive earnings, sales growth, and strong cash flow.
Via Chartmill · November 4, 2025
Global Payments (GPN) reported Q3 2025 results with a slight revenue miss but solid adjusted EPS growth and a 6.4% stock rise. The company advances its transformation and Worldpay acquisition.
Via Chartmill · November 4, 2025
Copart has considerably underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Via Barchart.com · November 4, 2025
Yum China reports Q3 2025 EPS of $0.76, beating estimates, with $3.21B revenue, 4% system sales growth, and 536 new stores added during the quarter.
Via Benzinga · November 4, 2025
Ichor (ICHR) Q3 2025 Earnings Call Transcript
Via The Motley Fool · November 4, 2025
Casual restaurant chain Portillo’s (NASDAQ:PTLO) missed Wall Street’s revenue expectations in Q3 CY2025 as sales only rose 1.8% year on year to $181.4 million. Its GAAP profit of $0.02 per share was $0.02 below analysts’ consensus estimates. 
Via StockStory · November 4, 2025
Robotics is an interesting opportunity, but choosing individual stocks isn't for everyone.
Via The Motley Fool · November 4, 2025
Charles Schwab has outperformed the broader market over the past year, and analysts are cautiously optimistic about the stock’s prospects.
Via Barchart.com · November 4, 2025
Gaia (GAIA) Q3 2025 Earnings Call Transcript
Via The Motley Fool · November 4, 2025
Pfizer beat third-quarter expectations Tuesday, though both sales and profit fell year over year. The company also hiked its profit view.
Via Investor's Business Daily · November 4, 2025
Goldman Sachs and Morgan Stanley's CEOs have issued a warning about a potential market correction within the next two years.
Via Benzinga · November 4, 2025
Fiber laser manufacturer IPG Photonics (NASDAQ:IPGP) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 7.6% year on year to $250.8 million. Guidance for next quarter’s revenue was better than expected at $245 million at the midpoint, 1.1% above analysts’ estimates. Its non-GAAP profit of $0.35 per share was 78.8% above analysts’ consensus estimates. 
Via StockStory · November 4, 2025
Kosmos Energy (KOS) Q3 2025 Earnings Call Transcript
Via The Motley Fool · November 4, 2025
STRIDE INC (LRN) excels with strong revenue growth, high profitability, and exceptional capital returns, making it a top pick in the Caviar Cruise quality investing screen.
Via Chartmill · November 4, 2025
Uber’s third-quarter performance exceeded forecasts, highlighting solid growth and continued confidence in its outlook for year-end.
Via Talk Markets · November 4, 2025
Fast-food chain Wingstop (NASDAQ:WING) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 8.1% year on year to $175.7 million. Its non-GAAP profit of $1.09 per share was 18.6% above analysts’ consensus estimates. 
Via StockStory · November 4, 2025
Boeing has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.
Via Barchart.com · November 4, 2025
Hardware products and merchandising solutions provider Hillman (NASDAQ:HLMN) met Wall Streets revenue expectations in Q3 CY2025, with sales up 8% year on year to $424.9 million. On the other hand, the company’s full-year revenue guidance of $1.56 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP profit of $0.22 per share was 7.6% above analysts’ consensus estimates. 
Via StockStory · November 4, 2025
Stephen Weiss of Short Hills Capital Partners recommended buying Meta Platforms, which is down almost 20% from the high.
Via Benzinga · November 4, 2025